5-Aminolevulinic acid and its derivatives: Physical chemical properties and protoporphyrin IX formation in cultured cells

Journal of Photochemistry and Photobiology B: Biology

Volumn 54, Issue 1, 2000, Pages 72-80

  Uehlinger, Pascal ^a   Zellweger, Matthieu ^a   Wagnières, Georges ^a   Juillerat Jeanneret, Lucienne ^b   Van Den Bergh, Hubert ^a   Lange, Norbert ^a  

^a EPFL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

5 Aminolevulinic acid; 5 Aminolevulinic acid esters; ALA esters; Fluorescence; Lipophilicity; Photodynamic therapy (PDT); Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID DERIVATIVE; ESTER; OCTANOL; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; UNCLASSIFIED DRUG; WATER;

ABSORPTION SPECTROSCOPY; ARTICLE; BLADDER; CELL VIABILITY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; LIPOPHILICITY; LUNG ALVEOLUS CELL; PARTITION COEFFICIENT; PH; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0033999403     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(99)00159-1     Document Type: Article

References (40)

1. Peng Q., Berg K., Moan J., Kongshaug M., Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem. Photobiol. 65:1997;235-251.
2. Kondo M., Hirota N., Takaoka T., Kajiwara M. Heme-biosynthesis enzyme activities and porphyrin accumulation in normal and hepatoma cell lines of rats. Cell Biol. Toxicol. 9:1993;95-105.
3. Hinnen P., De Rooij F.W.M., van Velthuysen M.L.F., Edixhoven A., van Hillegersberg R., Tilnaus H.W., Wilson J.H.P., Siersema P.D. Biochemical basis of 5-aminolevulinic acid-induced protporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the esophagus. Br. J. Cancer. 78:1998;679-682.
4. Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B: Biol. 14:1992;275-292.
5. Baumgartner R., Huber R.M., Schulz H.-J., Stepp H., Rick K., Gamarra F., Leberig A., Roth C. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J. Photochem. Photobiol. B: Biol. 36:1996;167-174.
6. Jichlinski P., Forrer M., Mizeret J., Glanzmann T., Braichotte D., Wagnières G., Zimmer G., Guillou L., Schmidlin F.M., Graber P., van den Bergh H., Leisinger H.-J. Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg. Med. 20:1997;402-408.
7. Kriegmair A., Baumgartner R., Knuechel R., Steinbach P., Ehsan A., Lumper W., Hostädter F., Hofstetter A. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology. 44:1994;836-841.
8. Kriegmair M., Baumgartner R., Lumper W., Waidelich R., Hofstetter A. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br. J. Urol. 77:1996;667-671.
9. Kriegmair M., Baumgartner R., Knuechel R., Stepp H., Steinbach P., Hofstaedter F., Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J. Urol. 155:1996;105-110.
10. Gossner L., Stolte M., Sroka R., Rick K., May A., Hahn E.G., Ell C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 114:1998;448-455.
11. Fan K.F.M., Hopper C., Speight P.M., Buonaccorsi G., Macrobert A.J., Bown S.G. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer. 78:1996;1374-1383.
12. Wyss P., Fehr M., van den Bergh H., Haller U. Feasibility of photodynamic endometrial ablation without anesthesia. Int. J. Gynec. Obstet. 60:1998;287-288.
13. Stummer W., Stocker S., Wagner S., Stepp H., Fritsch C., Goetz C., Goetz A.E., Kiefmann R., Reulen H.J. Intraoperative detection of malignant glioma by 5-ALA-induced porphyrin fluorescence. Neurosurgery. 42:1998;518-525.
14. Wagnières G., Hadjur C., Grosjean P., Braichotte D., Savary J.-F., Monnier P., Bergh H.v.d. Clinical evaluation of the cutaneous phototoxicity of a second generation photosensitizer for PDT: mTHPC. Photochem. Photobiol. 68:1998;382-387.
15. Grönlund-Pakkanen S., Mäkinen K., Talja M., Kuusisto A., Alhava E. The importance of fluorescence distribution and kinetics of ALA-induced PpIX in the bladder in photodynamic therapy. J. Photochem. Photobiol. B: Biol. 38:1997;269-273.
16. Martin A., Tope W.D., Grevelink J.M., Starr J.C., Fewkes J.L., Flotte T.J., Deutsch T.F., Anderson R.R. Lack of selectivity of protoporphyrin-IX fluorescence for basal-cell carcinoma after topical application of 5-aminolevulinic acid - implications for photodynamic treatment. Arch. Dermatol. Res. 287:1995;665-674.
17. Webber J., Kessel D., Fromm D. Side-effects and photosensitization of human tissues after aminolevulinic acid. J. Surg. Res. 68:1997;31-37.
18. Fiedler D.M., Eckl P.M., Krammer B. Does delta-aminolevulinic-acid induce genotoxic effects. J. Photochem. Photobiol. B: Biol. 33:1996;39-44.
19. Marti A., Lange N., van den Bergh H., Sedmera D., Kucera P. Optimalisation of the formation and distribution of Protoporphyrin IX in the urothelium: an in vitro approach. J. Urology. 162:1999;546-552.
20. Kloek J., Beijersbergen van Henegouwen G.M.J. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem. Photobiol. 64:1996;994-1000.
21. Kloek J., Akkermans W., Beijersbergen van Henegouwen G.M.J. Derivatives of 5-aminolevulininc acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem. Photobiol. 67:1998;150-154.
22. Gaullier J.-M., Berg K., Peng Q., Anholt H., Selbo P.K., Ma L.-W., Moan J. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res. 57:1997;1481-1486.
23. Lange N., Jichlinski P., Zellweger M., Forrer M., Marti A., Guillou L., Kucera P., Wagnières G., van den Bergh H. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br. J. Cancer. 80:1999;185-193.
24. Novo M., Hüttmann G., Diddens H. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. J. Photochem. Photobiol B: Biol. 34:1996;143-148.
25. R.O. Potts, R.H. Guy, The prediction of percutaneous penetration: a mechanistical model, in: R. Gurny, A. Teubner (Eds.), Dermal and Transdermal Drug Delivery: New Insights and Perspectives, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1993, pp. 153-160.
26. Bridges J.W., Sargent N.S.E., Upshall D.G. Rapid absorption from the urinary bladder of a series of n-alkyl carbamate: a route for the recirculation of drug. Br. J. Pharmacol. 66:1979;283-289.
27. Iinuma S., Farshi S.S., Ortel B., Hasan T. A mechanistic study of cellular photodestruction with 5-aminoleculinic acid-induced porphyrin. Br. J. Cancer. 70:1994;21-28.
28. Krammer B., Ueberriegler K. In vitro investigation of ALA-induced protoporphyrin IX. J. Photochem. Photobiol. B: Biol. 36:1996;121-126.
29. Moan J., Streckyte G., Bagdonas S., Bech O., Berg K. Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid. Int. J. Cancer. 70:1997;90-97.
30. Rossi F.M., Campbell D.L., Pottier R.H., Kennedy J.C., Gudgin Dickson E.F. In vitro study on the potential use of 5-aminolevulinic acid mediated photodynamic therapy for gynaecological tumours. Br. J. Cancer. 74:1996;881-887.
31. He D., Behar S., Nomura N., Sassa S., Liu H.W. The effect of ALA and radiation on porphyrin/heme biosynthesis in endothelial cells. Photochem. Photobiol. 61:1995;656-661.
32. Gibson S.L., Haves J.J., Foster T.H., Hilf R. Time-dependent intracellular accumulation of d-aminolevulinic acid, induction of porphyrin synthesis and subsequent phototoxicity. Photochem. Photobiol. 65:1997;416-421.
33. Fraga C.G., Onuki J., Lucesoli F., Bechara E.J., Di Mascio P. 5-Aminolevulinic acid mediates the in vivo and in vitro formation of 8-hydroxy-2′-deoxyguanosine in DNA. Carcinogenesis. 15:1994;2241-2244.
34. 2+ and 5-aminolevulinic acid-derived oxyradicals promote injury to isolated mitochondria? Free Radical Bio. Med. 19:1995;381-390.
35. Beerg K., Anholt H., Bech O., Moan J. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolevulinic acid-treated cells. Br. J. Cancer. 74:1996;688-697.
36. Fuchs C., Riesenberg R., Siebert J., Baumgartner R. pH-Dependent formation of 5-aminolevulinic acid-induced protoporphyrin IX in fibrosarcoma cells. J. Photochem. Photobiol. B: Biol. 40:1997;49-54.
37. Wyld L., Reed M.W.R., Brown N.J. The influence of hypoxia and pH on aminolevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro. Br. J. Cancer. 77:1998;1621-1627.
38. Bermutz M., Moretti C.G.S., Stella C., Ramos E., Battle A.d.C. Delta-aminolevulinic acid transport in Saccaroma cerevisiae. Int. J. Biochem. 25:1993;1917-1924.
39. Musgrove E., Seaman M., Hedley D. Relationship between cytoplasmatic pH and proliferation during exponential growth and cellular quiescence. Exp. Cell Res. 172:1987;65-75.
40. E. Rud, G. Gederaas, S.B. Brown, J.A. Holroyd, D. Vernon, A. Hogset, J. Moan, K. Berg, Cellular uptake mechanisms for 5-aminolevulinic acid and 5-aminolevulinic methyl ester, 8th Congress Eur. Soc. Photobiol., Granada, Spain, Book of Abstracts, S136, 1999, p. 85.